Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-11
2009-10-27
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S238000, C544S240000, C560S034000, C560S051000, C560S169000, C560S125000
Reexamination Certificate
active
07608621
ABSTRACT:
The invention described herein relates to certain pyridazinedione N-substituted glycine derivatives of formula (I)which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
REFERENCES:
patent: 2001/0007869 (2001-07-01), Bare et al.
patent: 2004/0063709 (2004-04-01), Taveras et al.
patent: 2006/0276477 (2006-12-01), Klaus et al.
Mikhail, et al., Kidney & Blood Pressure Research, 2008;31:234-246.
Duffy Kevin J.
Miller William Henry
Myers Andrea K.
Shaw Antony N.
Zimmerman Michael N.
Gimmi Edward R.
Jaisle Cecilia M
Kanagy James M.
Kinzig Charles M.
SmithKline Beecham Corp.
LandOfFree
N-substituted glycine derivatives: hydroxylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted glycine derivatives: hydroxylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted glycine derivatives: hydroxylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4053778